FDA Finds Cancer-Causing Agent in Metformin
| Pharmaceutical Litigation
The sudden recall of a popular diabetes drug because of NDMA contamination (cancer-causing agent) creates a cloud over the Food and Drug Administration’s entire review process. Time-Cap Labs Inc.’s generic drug is used to treat Type 2 diabetes. Its lower cost makes it a popular alternative to brand-name drugs. When the most recent test results…Read the article